News
News
- Cerner to Present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:00 - GlobeNewswire - Sterling Metals Reports Rock Grab Samples Assaying 6,783.2 and 3,172.0 g/t Ag Equivalent from the Sail Pond Project, Newfoundland
01/06/2021 / 13:30 - Newsfile Corp - Fabled Announces Surface Sampling Over IP Anomalies Results In Three Areas of Highly Anomalous Silver Values and Update on Current Drilling
01/06/2021 / 13:00 - Newsfile Corp - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease
01/06/2021 / 13:00 - GlobeNewswire - National General Announces Notice to Redeem Certain of its Securities and Intention to Delist and Deregister its Series C Depositary Shares
01/04/2021 / 22:05 - GlobeNewswire - Tara Subkoff teams up with Sisters, Martha Plimpton and Sorel Carradine for Hilarious Holiday Video
12/24/2020 / 05:00 - GlobeNewswire - THE BRUNSWICK – A MULTIFAMILY PUBLIC-PRIVATE PROJECT DEVELOPED IN PARTNERSHIP WITH THE CITY OF NORCROSS – IS NOW OPEN AND 40% LEASED
12/22/2020 / 14:00 - GlobeNewswire - Sumitovant Biopharma Announces Myovant Sciences receives FDA Approval of ORGOVYXTM (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
12/18/2020 / 23:46 - GlobeNewswire - Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
12/18/2020 / 22:49 - GlobeNewswire - CLAYTON & LITTLE IS NOW CLAYTON KORTE
12/17/2020 / 23:06 - GlobeNewswire
Real-time